List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 69 studies with search of:   Tanzania
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Efficacy of Sulphadoxine-Pyrimethamine and Artemisinin-Containing Combination Therapy for Malaria
Condition: Malaria (Uncomplicated)
Interventions: Drug: Sulfadoxine-pyrimethamine;   Drug: sulfadoxine-pyrimethamine plus artesunate;   Drug: lumefantrine plus artemether;   Behavioral: Sleeping under insecticide-treated bednet
2 Completed RBx11160 Phase II Dose Ranging Study RBx/MMV05-06
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: Treatment with 3 dose groups of RBx11160 over 7 days
3 Recruiting Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy
Condition: Malaria
Interventions: Drug: sulfadoxine/pyrimethamine;   Drug: sulfadoxine/pyrimethamine plus artesunate
4 Completed HIV Prevention Preparedness Study
Conditions: HIV Infections;   HIV Seronegativity
Intervention:
5 Completed Efficacy and Cost Effectiveness of Malaria Diagnosis Procedures and the Rational Use of ACT in Zanzibar
Condition: Malaria
Intervention: Device: Rapid Diagnostic Test for P. falciparum malaria
6 Active, not recruiting The Community Effectiveness of IPTi in Southern Tanzania
Conditions: Malaria, Falciparum;   Anemia
Interventions: Drug: Sulfadoxine-pyrimethamine used for IPTi;   Drug: IPTi
7 Completed TB Nutrition, Immunology and Epidemiology
Condition: Mycobacterium Tuberculosis
Interventions: Drug: Folic Acid;   Drug: Micronutrients: Vitamins B1, B2, B6, Niacin, B12, C, E.;   Drug: Selenium;   Drug: Vitamin A
8 Not yet recruiting FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada®;   Drug: Placebo
9 Active, not recruiting Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
Conditions: HIV Infections;   Gonorrhea;   Chlamydial Infections;   Genital Herpes
Intervention: Drug: PRO 200/5
10 Completed Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: chlorproguanil-dapsone-artesunate;   Drug: artemether-lumefantrine
11 Active, not recruiting Study of Three Alternatives for Mass Treatment in Trachoma Villages of Tanzania
Condition: Trachoma
Intervention: Behavioral: community surveillance and re-treatment
12 Active, not recruiting Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen
Conditions: Plasmodium Falciparum;   Malaria
Interventions: Biological: Stamaril™;   Biological: Tritanrix HepB™/Hiberix™;   Biological: Measles vaccine;   Biological: Polio Sabin™;   Biological: GSK Malaria vaccine 257049
13 Not yet recruiting Mass Oral Cholera Vaccination in Zanzibar
Conditions: Cholera;   Diarrhea
Intervention: Biological: rBS-WC vaccine
14 Recruiting Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo
15 Active, not recruiting Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-School Children in, Tanzania
Conditions: Anaemia;   Malaria;   Hepatosplenomegaly
Intervention: Drug: Albendazole and praziquantel
16 Not yet recruiting Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
17 Terminated IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
Condition: Malaria
Interventions: Drug: sulphadoxine/pyrimethamine;   Drug: Chlorproguanil/dapsone;   Drug: Sulfadoxine/pyrimethamine
18 Completed Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers
Condition: Uncomplicated Plasmodium Falciparum Malaria
Intervention: Device: Rapid diagnostic test for malaria
19 Completed Mass-Drug Administration to Reduce Malaria Transmission
Condition: Malaria, Falciparum
Interventions: Drug: Sulphadoxine-pyrimethamine (day 1: 500mg S&25mg P/20 kg);   Drug: Artesunate (day 1,2,3: 4 mg/kg);   Drug: Primaquine-base (day 3: 0.75 mg/kg);   Drug: placebo tablets
20 Active, not recruiting Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission
Conditions: HIV Infection;   Herpes Simplex, Genital;   Sexually Transmitted Diseases
Intervention: Drug: Generic acyclovir and matching placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services